Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Laquinimod in Primary Progressive Multiple Sclerosis
NCT02284568Phase 2Completed
- Sponsor
- Teva Pharmaceutical Industries Ltd.
- Start
- Jan 2015
- Primary completion
- May 2017
- Modality
- Small Molecules
- Countries
- 10
01
Overview
A Phase 2 trial of laquinimod in primary progressive multiple sclerosis (PPMS), sponsored by Teva Pharmaceutical Industries Ltd.. Started Jan 2015; status: completed.
02
Drugs
laquinimod
03
Conditions
primary progressive multiple sclerosis (PPMS)
Beyond the preview
Go deeper on NCT02284568.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02284568.